The DOI matches its Crossref record; 16 of the 18 references it cites were found in a registry or an index.
Selective Serotonin Reuptake Inhibitor Usage Patterns as Risk Factors for Hospitalization
Abstract
The authors examined how differences in SSRI utilization affect the risk of hospitalization among persons with depression. In particular, they decompose how different types of drug therapy affect hospitalization and how that effect varies with the usage pattern of the drug. Using retrospective medical and pharmacy claims from a Midwestern health maintenance organization, they employed multiple logistic regression analyses of patients newly treated for depression. Their findings were that (a) paroxetine may be a significant risk factor for early discontinuation compared with fluoxetine; and (b) sertraline initiation among stable-use patients may lower the risk of hospitalization. However, initiation on paroxetine or sertraline rather than fluoxetine may increase the risk of hospitalization among patients not exhibiting a stable usage pattern.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Accordingly, the treatment of patients with TRD is associated with an increase in healthcare resource utilization (HCRU) and economic cost, due to a higher number of visits to both primary and secondary care practitioners, a higher rate of hospitalizations, and more psychiatric prescriptions including anxiolytics, hypnotics and antipsychotics 17,19,20 .”
Citations
Cites
Kessler, R. C. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950010008002 · Cited by 12,370
The de Facto US Mental and Addictive Disorders Service System
Regier, D. A. (1993) · Archives of General Psychiatry · doi:10.1001/archpsyc.1993.01820140007001 · Cited by 2,001
Agency for Health Care Policy and Research
Eisenberg, J. M. (1999) · Medical Care · doi:10.1097/00005650-199903000-00001 · Cited by 1,373
Greenberg, P. E., Stiglin, L. E., Finkelstein, S. N., & Berndt, E. R. (1994) · PharmacoResources · doi:10.1007/bf03289581 · Cited by 975
Utilization of Health and Mental Health Services
Shapiro, S. (1984) · Archives of General Psychiatry · doi:10.1001/archpsyc.1984.01790210053007 · Cited by 809
The economic burden of depression
Stoudemire, A., Frank, R. W., Hedemark, N., Kamlet, M. S., & Blazer, D. G. (1986) · General Hospital Psychiatry · doi:10.1016/0163-8343(86)90018-6 · Cited by 480
Initial Antidepressant Choice in Primary Care
Simon, G. E. (1996) · JAMA · doi:10.1001/jama.275.24.1897 · Cited by 311
Antihypertensive pharmacotherapy: Economic outcomes in a health maintenance organization
Sclar, D. A., Skaer, T. L., Robison, L. M., Legg, R. F., & Nemec, N. L. (1994) · Current Therapeutic Research · doi:10.1016/s0011-393x(05)80275-9 · Cited by 89
Patterns of Antidepressant Use and Their Relation to Costs of Care
Thompson, D. R., Buesching, D. P., Gregor, K. J., & Oster, G. (1996) · The American Journal of Managed Care · Cited by 85
Sclar, D. A., Robison, L. M., Skaer, T. L., Galin, R. S., Legg, R. F., Nemec, N. L., Hughes, T. E., Buesching, D. P., & Morgan, M. (1995) · Journal of International Medical Research · doi:10.1177/030006059502300601 · Cited by 82
Effect of antidepressant therapy on health care utilization and costs in primary care
Croghan, T. W., Lair, T. J., Engelhart, L., Crown, W. E., Copley‐Merriman, C., Melfi, C. A., Obenchain, R. L., & Buesching, D. P. (1997) · Psychiatric Services · doi:10.1176/ps.48.11.1420 · Cited by 73
Course and cost of treatment for depression with fluoxetine, paroxetine, and sertraline.
Jm, R., Berndt, E. R., Miceli, R., Colucci, S. V., & Grudzinski, A. N. (1999) · PubMed · Cited by 39
SSRI Antidepressant Drug Use Patterns in the Naturalistic Setting
Hylan, T. R., Crown, W. H., Meneades, L. M., Heiligenstein, J. H., Melfi, C. A., Croghan, T. W., & Buesching, D. P. (1999) · Medical Care · doi:10.1097/00005650-199904001-00007 · Cited by 34
Antidepressant Selection and Use and Healthcare Expenditures
Crown, W. H., Hylan, T. R., & Meneades, L. M. (1998) · PharmacoEconomics · doi:10.2165/00019053-199813040-00006 · Cited by 33
Cost Implications of Initial Antidepressant Selection in Primary Care
Simon, G. E., & Fishman, P. A. (1998) · PharmacoEconomics · doi:10.2165/00019053-199813010-00006 · Cited by 32
Measuring Prices and Quantities of Treatment for Depression
Frank, R. G., Busch, S. H., & Berndt, E. R. (2016) · American Economic Review · Cited by 27
Research works printed but not linked: 1
- Way, K., Young, C.H., Opland, E., Whitehouse, D., & Hughes, T. (1999). Antidepressant utilization patterns in a national managed care organization. Drug Benefit Trends, 11(9), 6-11.
Cited by
Antidepressant monotherapy: A claims database analysis of treatment changes and treatment duration
Milea, D., Guelfucci, F., Bent‐Ennakhil, N., Toumi, M., & Auray, J. (2010) · Clinical Therapeutics · doi:10.1016/j.clinthera.2010.11.011 · Cited by 64
The Marketization of Depression: The Prescribing of SSRI Antidepressants to Women *
Currie, J. (2005) · Cited by 49
Saragoussi, D., Chollet, J., Bineau, S., Chalem, Y., & Milea, D. (2012) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2012.03015.x · Cited by 30
Béland, S., Tournier, M., du Fort, G. G., Crott, R., Ducruet, T., Pariente, A., & Moride, Y. (2011) · Value in Health · doi:10.1016/j.jval.2010.11.015 · Cited by 15
Young, A. H., Evitt, L., Brignone, M., Diamand, F., Atsou, K., Campbell, R., Cure, S., & Danchenko, N. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.04.019 · Cited by 15
Metadata
- Authors
- Sheffield, R. E., Sasso, A. T. L., Young, C. H., & Way, K.
- Affiliations
- Northwestern University (US)
- Corresponding author
- Sasso, Anthony T. Lo
- ORCID
- Sasso, Anthony T. Lo
- Venue
- Administration and Policy in Mental Health and Mental Health Services Research
- Published
- 2002-11
- Volume
- 30
- Issue
- 2
- Pages
- 121-139
- ISSN
- 0894-587X (ISSN-L)
- 1573-3289
- OpenAlex
- W1586269303
- Cited by
- 11
- References
- 18
- Citations by year
- 2020: 1 · 2019: 1 · 2018: 1 · 2017: 1 · 2012: 1
- FWCI
- 0.61
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- Administration and Policy in Mental Health and Mental Health Services Research (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
- Keywords
- selective serotonin reuptake inhibitors, depression, hospitalization, paroxetine, fluoxetine, sertraline, drug utilization patterns, drug discontinuation, antidepressant initiation, risk factors
- MeSH terms
- Depressive Disorder, Fluoxetine, Health Maintenance Organizations, Hospitalization, Humans, Medical Audit, Retrospective Studies, Risk Factors, Midwestern United States, Selective Serotonin Reuptake Inhibitors, Paroxetine, Drug Utilization Review, Antidepressive Agents, Second-Generation, Sertraline
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
